Are supplements FDA approved? No, and what protects you

October 6, 2026

Various dietary supplement pills and capsules

No. The FDA does not review or approve a dietary supplement before it goes on sale, under a law called DSHEA. The agency's role starts only after a product is already on shelves, and the burden of proof sits with the manufacturer, not the government. What actually protects you is facility compliance, batch testing, and full-dose labeling.

People assume otherwise because the bottle looks the part. It sits a few feet from the pharmacy counter, it carries a serious-looking label, sometimes the letters "FDA" even appear on it somewhere. None of that is an approval. Once you know what the FDA actually checks, and when, it is easier to see what you should be checking yourself.

What does the law actually say?

The Dietary Supplement Health and Education Act of 1994, usually shortened to DSHEA, is the law that set up the current system [2]. Under it, "FDA is not authorized to approve dietary supplements for safety and effectiveness before they are marketed" [1]. That is not a loophole or an oversight. It's the design.

Practically, that means a company can launch a new creatine or protein product without clearing it with anyone first. FDA's own Q&A page puts it plainly: "generally, a firm does not have to provide FDA with the evidence it relies on to substantiate safety before or after it markets its products" [2]. The company decides its product is safe, decides its label is accurate, and ships it.

There is exactly one pre-market contact point, and it is narrow. If an ingredient is genuinely new, meaning it "was not marketed in the United States before October 15, 1994" [2], the company must notify FDA "at least 75 days before introducing" it for sale [2]. But this is a safety notice, not a review of whether the ingredient works, and it only applies to ingredients that are actually new.

What does the FDA do, then?

Everything after the sale. The FDA's consumer guidance describes its job as "identifying and removing unsafe and illegal products from the market" [1], which is a different verb than "approving." A product has to actually be adulterated, mislabeled, or making an illegal claim before FDA has anything to act on [2].

That enforcement is real, just reactive. In one 2022 action, FDA sent warning letters to several companies over supplements containing new dietary ingredients it had never received the required notification for and, in some cases, disease claims that made the products unapproved new drugs [5]. FDA's announcement was explicit about what the agency had not done: "the agency has not evaluated whether the unapproved products subject to the warning letters announced today are effective for their intended use, what the proper dosage might be... or whether they have dangerous side effects or other safety concerns" [5]. That sentence is the whole system in one line. The product was on sale first. The scrutiny came after, and only because something had already gone wrong.

There is also a reporting layer that runs the other direction: "manufacturers and distributors of dietary supplements must record, investigate, and forward to FDA any reports they receive of serious adverse events" [2]. It catches harm after it happens, which matters, but it is not the same thing as a label being checked before a customer ever opens it.

So what actually protects you, if approval doesn't exist?

Three things, roughly in the order you can check them yourself.

Does the facility follow cGMP?

Current Good Manufacturing Practice, cGMP for short, is a federal rule under 21 CFR Part 111. It requires a manufacturer to set written specifications for "the finished batch of the dietary supplement," covering "identity, purity, strength, and composition," and to actually test against those specifications rather than just assume them [3]. A facility has to "verify that a subset of finished dietary supplement batches... meets product specifications" [3]. That is a real, written standard a batch can be measured against, and it is the first filter between "whatever the factory happened to produce" and "what the label says is in the tub."

It is also the facility-level claim worth paying attention to on a label, and AUROM makes exactly two of that kind: made in a cGMP-compliant facility, and made in the USA. Nothing wider than that. For more on what the phrase does and does not promise, see what cGMP actually means on a supplement label.

Is there a certificate of analysis for this batch?

cGMP requires the testing. A Certificate of Analysis, or COA, is the document that shows the result of it for a specific batch: what was actually measured, and whether it matched. It is not a certification and nobody should present it as one. It's closer to a receipt. AUROM's creatine monohydrate has a Certificate of Analysis available per batch, on request, so what the label promises is something you can actually check against a real lab result rather than take on faith.

A COA is also not the same thing as the badge-heavy claim "third-party tested," which gets used loosely enough to mean almost anything. If you want the distinction in full, what "third-party tested" actually means, and doesn't covers it.

Does the label print the full dose?

This is the one almost nobody checks, because the law does not require it to be checked. A "proprietary blend" is legal to sell with only the blend's total weight disclosed. The regulation requires the ingredients to be "declared in descending order of predominance by weight," and the blend's combined weight to be listed, but it does not require the amount of any single ingredient inside that blend to appear anywhere on the label [4]. A tub can be completely legal, fully cGMP compliant, and still tell you almost nothing about how much of anything you are actually getting.

The fix is not a certification. It is just printing the number. AUROM's creatine is one ingredient, one dose, 5 g a scoop, with nothing else in the formula to blend it into. There is no blend for the law to let hide behind.

Why does the FDA disclaimer line even exist?

You've seen it at the bottom of almost every supplement label, and pages like this one: the sentence about the FDA not having evaluated the statements, and the product not being intended to diagnose, treat, cure, or prevent disease. It looks like boilerplate. It's actually doing real work.

It exists because of the gap this whole post describes. A company is allowed to say that an ingredient supports a normal body function, something called a structure/function claim, without proving that claim to FDA first the way a drug company has to [2]. The disclaimer is the label's admission of that fact, stated out loud instead of buried: nobody at the FDA checked this sentence before it went on the bottle. It is not a warning that the product is weaker than a drug, just an honest description of who checked what, and when.

Questions people actually ask

Is an "FDA registered facility" the same as FDA approved? No. Registering a facility is closer to notifying FDA that it exists, which a facility must do before it begins operations [2]. cGMP compliance, under 21 CFR Part 111, is the actual manufacturing standard a facility has to meet [3]. Neither one is an approval of a product [1].

Can the FDA take a supplement off the market? Yes, after the fact. If a product turns out to be adulterated, mislabeled, or making an illegal disease claim, FDA can send a warning letter and, if the company does not correct the problem, pursue legal action including product seizure or an injunction [5]. It is enforcement against a specific violation, not a pre-market check.

Does "clinically proven" mean FDA cleared the claim? No, and that phrase is a certification claim dressed as a research claim. FDA does not pre-clear structure/function statements [2], and AUROM does not use that phrase at all, for exactly this reason.

If there's no approval, why trust any brand's label? You don't have to take it on faith. Check for the three things that are actually verifiable: a cGMP-compliant facility, a batch-level Certificate of Analysis you can ask for, and a full dose printed with no blend hiding part of it.

Does the FDA test supplements itself before they're sold? No. Testing a finished batch against its own specifications is the manufacturer's legal responsibility under cGMP, not something FDA does before a product reaches a shelf [3].

The honest version is still a good one

"Nobody approved this" sounds worse than it is, once you know what the alternative actually looks like: a manufacturer deciding its own label is accurate, with no outside check until a complaint or an enforcement action brings one [5]. The honest answer is that the system relies on the manufacturer being willing to show its work before anyone asks. A cGMP-compliant facility, a batch-level Certificate of Analysis, and a label with the full dose printed on it are the three ways a company actually shows that work. Approval was never on the table. Those three things were.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.